SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: billkirn who wrote (3875)2/26/1998 10:28:00 AM
From: mod  Read Replies (1) | Respond to of 6136
 
Salomon Smith Barney initiated coverage today of Agouron with a 2S (Outperform, Speculative risk) rating and a one-year price target of $51, or 27 times their calendar year 1999 EPS estimate of $1.90.

Dennis